Company intelligence / Profile preview

JBKLAB

Seongnam-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

JBKLAB is an active South Korean biotech company specializing in natural substance-based nano-complexes for use as both functional foods and potential pharmaceuticals. The company’s R&D and patent portfolio target cancer, aging, and metabolic diseases using nanoparticle complexes derived from plant extracts, notably anthocyanin combinations. Operations include research institutes, manufacturing, and a branch in the US. No evidence of advanced clinical programs (i.e., no public phase 1+ data); activities center on preclinical R&D, patent filings, and functional food market presence.

Therapeutic areas: EndocrinologyGastroenterologyCardiovascularOtherOncology
Modalities: Small moleculeBiologicNanoparticleFunctional food
Industry: Biotech

Drug pipeline

5 assets

Bioflex F

Unknown

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on JBKLAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JBKLAB.

Explore the full profile